- cafead   Sep 30, 2021 at 11:32: PM
via The U.S. House Judiciary Committee voted Thursday to approve a fourth bill aimed at tackling high drug prices, approving a measure that would make it easier for biosimilar drugs, cheaper versions of expensive biotech drugs, to come to market.
article source
article source